Serena De Matteis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Serena De Matteis has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Davide Melisi
University of Verona, Verona, Italy
1 shared publication - Domenico Mangiameli
Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, 37134 Verona, Italy
1 shared publication - Fabio Sabbadini
Digestive Molecular Clinical Oncology Research Unit, Università degli studi di Verona, Verona, Italy
1 shared publication - Monica Bertolini
Digestive Molecular Clinical Oncology Research Unit, Università degli studi di Verona, Verona, Italy
1 shared publication - Serena Contarelli
University of Verona, Verona, Italy
1 shared publication - Silvia Pietrobono
Department of Medicine, Digestive Molecular Clinical Oncology Research Unit, University of Verona, Verona, Italy
1 shared publication
Latest Publications
- Open Access
The Multifaceted Role of TGF-β in Gastrointestinal Tumors
Transforming growth factor-beta (TGF-β) is a secreted cytokine that signals via serine/threonine kinase receptors and SMAD effectors. Although TGF-β acts as a tumor suppressor during the early stages of tumorigenesis, it supports tumor progression in advanced stages. Indeed, TGF-β can modulate the tumor microenvironment by modifying the extracellular matrix and by sustaining a paracrine interaction between neighboring cells. Due to its critical role in cancer development and progression, a wide range of molecules targeting the TGF-β signaling pathway are currently under active clinical development in different diseases. Here, we focused on the role of TGF-β in modulating different pathological processes with a particular emphasis on gastrointestinal tumors.
Open AccessThe Multifaceted Role of TGF-β in Gastrointestinal Tumors
Transforming growth factor-beta (TGF-β) is a secreted cytokine that signals via serine/threonine kinase receptors and SMAD effectors. Although TGF-β acts as a tumor suppressor during the early stages of tumorigenesis, it supports tumor progression in advanced stages. Indeed, TGF-β can modulate the tumor microenvironment by modifying the extracellular matrix and by sustaining a paracrine interaction between neighboring cells. Due to its critical role in cancer development and progression, a wide range of molecules targeting the TGF-β signaling pathway are currently under active clinical development in different diseases. Here, we focused on the role of TGF-β in modulating different pathological processes with a particular emphasis on gastrointestinal tumors.